This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

Brief

Pharmaceutical Company AstraZeneca Launches Digital Health Program in Israel

Alongside funding, the program will provide Israeli startups with mentorship and training

Meir Orbach 16:2527.11.19
London-listed pharmaceutical company AstraZeneca PLC has launched a program for investing in the digital health sector in Israel, AstraZeneca announced Wednesday. As part of the program, called BeyondBio, the company intends to make a first investment estimated at NIS 10 million (approximately $2.8), according to a statement. Alongside funding, the program will provide Israeli startups with mentorship and training.

 

The program is operated in collaboration with Israel-based venture capital firm Jerusalem Venture Partners (JVP); Israel Initiative 2020 (ii2020), a nonprofit founded by JVP founder Erel Margalit; Maccabitech, the research and innovation wing of Israeli health maintenance organization Maccabi Healthcare Services; Israeli businessman Morris Kahn; the Sagol Fund; and Microsoft.
AstraZeneca's headquarters in Cambridge, U.K. Photo: Getty Images AstraZeneca's headquarters in Cambridge, U.K. Photo: Getty Images